Sulfonated Polystyrene Derivatives for Specialized Feline Health Applications
Legal Citation
Summary of the Inventive Concept
The inventive concept adapts sulfonated polystyrene derivatives for treating and preventing feline diseases in unique operational environments, including high-altitude, high-security, extreme weather, disaster relief, and high-air-pollution settings.
Background and Problem Solved
The original patent discloses sulfonated polystyrene derivatives for treating and preventing cat flu. However, the original patent does not address the specific challenges posed by treating feline diseases in specialized environments, such as high-altitude, high-security, extreme weather, disaster relief, and high-air-pollution settings. The new inventive concept solves this problem by adapting the sulfonated polystyrene derivatives to withstand and mitigate the effects of these unique environments.
Detailed Description of the Inventive Concept
The inventive concept comprises sulfonated polystyrene derivatives formulated to address the specific challenges of treating feline diseases in high-altitude, high-security, extreme weather, disaster relief, and high-air-pollution settings. For example, the derivatives may be adapted to withstand extreme temperatures, high humidity, or air pollution. The derivatives may also be formulated to be used in high-security environments, such as animal shelters, or in disaster relief situations, where the availability of medical resources may be limited. The inventive concept also includes systems, methods, compositions, and kits for treating and preventing feline diseases in these unique operational environments.
Novelty and Inventive Step
The new claims introduce novel and non-obvious adaptations of sulfonated polystyrene derivatives for treating and preventing feline diseases in specialized environments. The inventive concept's formulation and adaptation of the derivatives to withstand and mitigate the effects of these unique environments constitute a significant inventive step over the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include sulfonated polystyrene derivatives adapted for use in other unique operational environments, such as space exploration or remote wilderness areas. Variations of the inventive concept may include the use of different types of sulfonated polystyrene derivatives or different formulations tailored to specific environmental challenges.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the veterinary pharmaceutical industry, particularly in the areas of feline health and disease prevention. The target market includes veterinarians, animal shelters, and pet owners who require effective treatments for feline diseases in specialized environments.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Veterinary pharmaceuticals, specifically feline viral disease treatment and prevention, with expertise in polymer chemistry and drug formulation for animal health applications
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degree in veterinary medicine or pharmaceutical sciences, understanding polymer chemistry, viral disease mechanisms, and drug delivery systems for animal health
Obviousness Rationale
A PHOSITA would recognize that sulfonated polystyrene derivatives can be readily adapted for different environmental conditions by modifying excipients, delivery mechanisms, and formulation parameters. The core therapeutic mechanism of treating feline viral infections remains consistent across the disclosed variations. The adaptations represent predictable engineering solutions to extend the original patent's core invention to specialized use contexts.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,566 |
|---|---|
| Title | Sulfonated polystyrene derivative for use in the treatment and/or prophylaxis of cat flu |
| Assignee(s) | UNIWERSYTET JAGIELLONSKI |